You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cardiovascular Disease Risk

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Among Youth With Type 1 Diabetes

Suspended
  • Type 1 Diabetes
  • Cardiovascular Risk Factor
    • Montréal, Quebec, Canada
      CHU Sainte-Justine
    Feb 22, 2022

    Healthy People Trial in Pomona (Grape Powder)

    Not yet recruiting
    • Healthy People
    • Grape Powder
    • Pomona, California
      Cal Poly Pomona
    Aug 20, 2023

    Cardiovascular Disease, Alcohol Use Disorder, HIV Risk Trial in New York (Navigation, compensation, and personalization)

    Not yet recruiting
    • Cardiovascular Disease
    • +3 more
    • Navigation, compensation, and personalization
    • New York, New York
      NYC H+H/Bellevue
    Apr 13, 2023

    Aging, Stress, Disease Risk Trial in San Francisco (Aerobic Training Intervention)

    Completed
    • Aging
    • +2 more
    • Aerobic Training Intervention
    • San Francisco, California
      University of California, San Francisco
    Jun 9, 2022

    Nutrition, Healthy, Knowledge, Attitudes, Practice, Self Efficacy Trial (Multi-level behavior-change intervention to strengthen

    Not yet recruiting
    • Nutrition, Healthy
    • +2 more
    • Multi-level behavior-change intervention to strengthen food- and diet-related capital to promote food security and diet quality among low-income Hispanic/Latino adults
    • (no location specified)
    Nov 14, 2022

    Diet, Cooking Trial run by the National Institutes of Health Clinical Center (CC) (Cooking Intervention)

    Recruiting
    • Diet
    • Cooking
    • Cooking Intervention
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Essential Hypertension, Motivational Interview, Cardiovascular Disease Risk Trial in Eskisehir (6-session motivational

    Enrolling by invitation
    • Essential Hypertension
    • +3 more
    • 6-session motivational interviews
    • +3 more
    • Eskişehir, Tepebaşı, Turkey
      Işıklar Family Health Center
    May 24, 2022

    Cardiovascular Disease Risk Reduction Trial in Tallahassee (Health for Hearts United Planning for Health, Health for Hearts

    Recruiting
    • Cardiovascular Disease Risk Reduction
    • Health for Hearts United Planning for Health
    • +3 more
    • Tallahassee, Florida
      Center on Better Health and Life for Underserved Populations
    Aug 1, 2022

    Cardiovascular Risk Factor, Lifestyle Risk Reduction Trial in Split (The letters with the Cochrane abstracts in the form of

    Completed
    • Cardiovascular Risk Factor
    • Lifestyle Risk Reduction
    • The letters with the Cochrane abstracts in the form of blog-shots
    • The letters with remainder on cardiovascular risk factors
    • Split, Croatia
      University of Split School of Medicine
    Nov 29, 2021

    Global Cardiovascular Risk Consortium

    Completed
    • Cardiovascular Diseases
    • +6 more
      • Hamburg, Germany
        University Medical Center Hamburg-Eppendorf
      Jul 18, 2022

      Score Among Primary Health Care Centre Attendees, Assiut

      Not yet recruiting
      • Cardiovascular Risk Score
      • Framingham study cardiovascular disease 10-years risk assessment score
      • (no location specified)
      Aug 9, 2022

      SB and Cardiac Function and Structure in IHD

      Not yet recruiting
      • Cardiovascular Diseases
      • Sedentary Behavior
      • Activity pattern in CVD
      • (no location specified)
      Mar 14, 2023

      Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)

      Not yet recruiting
      • Primary Prevention of Atherosclerotic Cardiovascular Disease
      • Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
      • Placebo in 1.5ml
      • (no location specified)
      Feb 13, 2023

      Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease

      Completed
      • Sarcopenia
      • +2 more
        • Shanghai, Shanghai, China
          Baoshan Site of Shanghai Renji Hospital, Shanghai Jiaotong Unive
        Jul 28, 2022

        PreDiabetes, Abdominal Obesity, Hypertension Trial in Beijing (Berberine plus lifestyle intervention, Placebo plus lifestyle

        Not yet recruiting
        • PreDiabetes
        • +3 more
        • Berberine plus lifestyle intervention
        • Placebo plus lifestyle intervention
        • Beijing, China
          Fuwai Hospital, Chinese Academy of Medical Sciences, National Ce
        Mar 6, 2023

        Diabetes and Heart Disease Risk in Blacks

        Recruiting
        • Cardiovascular Diseases
        • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 25, 2023

          Depression Mild, Cardiovascular Diseases Trial (MIYAIRI 588)

          Not yet recruiting
          • Depression Mild
          • Cardiovascular Diseases
          • MIYAIRI 588
          • (no location specified)
          Feb 9, 2023

          Dyslipidemia in Patients at High Risk and Very High Risk of

          Recruiting
          • Secondary Prevention
          • +2 more
          • application
          • Leon, Guanajuato, Mexico
            Umae Cmn T1
          Sep 13, 2022

          Cardiovascular Diseases, Heart Diseases, Cerebrovascular Disease Trial in Astros (Patient counselling)

          Recruiting
          • Cardiovascular Diseases
          • +9 more
          • Patient counselling
          • Astros, Greece
            Astros Health Care Center
          Oct 30, 2023

          l Gene Editing Therapy for Cardiovascular Disease

          Not yet recruiting
          • Atherosclerotic Cardiovascular Disease
          • +2 more
            • Auckland, New Zealand
            • +2 more
            Oct 31, 2023

            Cardiovascular Diseases, Healthy Trial in Innsbruck, Münster

            Recruiting
            • Cardiovascular Diseases
            • Healthy
              • Innsbruck, Tyrol, Austria
              • +1 more
              Jul 21, 2022

              Cardiovascular Diseases, Atherosclerosis, Lipoprotein(a) Trial (SLN360, Placebo)

              Not yet recruiting
              • Cardiovascular Diseases
              • +2 more
              • (no location specified)
              Sep 12, 2022

              Study to Evaluate the Risk of Cardiovascular Endpoints

              Completed
              • Pulmonary Disease, Chronic Obstructive
              • Aclidinium bromide
              • Other COPD medication
              • London, United Kingdom
                Clinical Practice Research Datalink
              Jan 30, 2023

              Cardiovascular Diseases, Periodontitis Trial in Guangzhou (Non-surgical periodontal therapy, Control periodontal treatment)

              Not yet recruiting
              • Cardiovascular Diseases
              • Periodontitis
              • Non-surgical periodontal therapy
              • Control periodontal treatment
              • Guangzhou, Guangdong, China
              • +1 more
              Jul 12, 2022

              ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

              Not yet recruiting
              • ASCVD
              • +3 more
              • (no location specified)
              Aug 3, 2023